Cardiac CT angiography may provide insights on common post-op complications of left atrial appendage closure, ranging from peri-device leaks to device-related thrombus, according to research presented at the American Roentgen Ray Society (ARRS) conference.
While transesophageal echocardiography has been the standard imaging utilized for post-op evaluation of left atrial appendage (LAA) closure, researchers at the American Roentgen Ray Society (ARRS) conference suggested that cardiac computed tomography angiography (CCTA) provides a less invasive option for assessing common complications.
Approximately 45 to 60 days after placement of the Watchman device for LAA closure in some patients with non-valvular atrial fibrillation, the researchers recommended the use off CCTA images near end-systole, subsequent multiplanar reconstruction (MPR) and short axis plane rotation to determine the presence of leaks in the long axis.
Patency of the LAA has been achieved if the LAA HU > 100 HU or the LAA/left atrium (LA) HU > 25 percent, according to the researchers. In the absence of a leak, the researchers noted that at least 50 HU lower contrast enhancement in the LAA in comparison to the left atrium indicates incomplete endothelialization.
Researchers at the American Roentgen Ray Society (ARRS) conference suggested that CCTA offers greater sensitivity than transesophageal echocardiography in assessing peri-device leaks, which can occur in over 65 percent of patients shortly after undergoing left atrial appendage (LAA) closure. (Images courtesy of ARRS.)
Pointing out that failed endothelialization, off-axis device positioning and failed expansion of the Watchman device against the LAA in the landing zone are common contributing factors with peri-device leaks, the researchers emphasized that CCTA facilitates optimal evaluation of these leaks, which can occur in over 65 percent of patients shortly after undergoing LAA closure.
“CT is more sensitive than echocardiography for the detection of (peri-device) leaks, especially for the detection of tiny marginal leaks, fabric leaks, and defects of endothelialization,” maintained lead poster author Aishwariya Vegunta, M.D., who is affiliated with the Department of Radiology at the University of Wisconsin School of Medicine and Public Health in Madison, Wisc.
Defining a peri-device leak as a contrast enhancement trail on CCTA that is adjacent to the Watchman device, the researchers noted that while peri-device leaks < 5 mm may spontaneously resolve with endothelialization, leaks > 5 mm require the use of oral anticoagulation therapy.
Other key considerations on CCTA include sub-fabric hypoattenuated thickening (HAT), device-related thrombus (DRT) and atrial septal defects (ASDs).
Atrial septal defects occur immediately after LAA closure procedures in 85 percent of patients and commonly seal by six-months post-op, according to Vegunta and colleagues. The researchers noted that a high thickness or pedunculated HAT suggests a potential DRT, and LAA thrombus is reportedly associated with a four- to fivefold increased risk for thromboembolic events.
“Cardiovascular imagers should be aware of the standardized CCTA acquisition and image interpretation including expected ‘normal’ findings and complications,” added Vegunta and colleagues.
(Editor’s note: For related content, see “What a New CT Study Reveals About Hypoattenuation Thickening After Left Atrial Appendage Occlusion (LAAO) Procedures,” “Study Suggests Benefits of Preoperative CT for Left Atrial Appendage Occlusion Procedures” and “Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque.”)
Reference
1. Vegunta A, Siembida JM, Priya S, Bluemke DA, Baliyan V, Nagpal P. Post LLA closure device placement cardiac CT imaging: technique and pearls. Presented at the American Roentgen Ray Society (ARRS) conference April 27-May 1, 2025, San Diego. Available at: https://www2.arrs.org/am25/ . Accessed April 28, 2025.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.